Please enable Javascript
Testicular, Penile, and Rare Malignancies
Advertisement
AUA Amendment to Testicular Cancer Guideline Includes New Treatment Options, Imaging Recommendations
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
September 15, 2023
The AUA released a new amendment to their 2019 guideline for the diagnosis and treatment of early-stage testicular cancer.
Read More
Study Identifies Risk Factors for Stage I Seminoma Relapse
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
September 13, 2023
Newly identified risk factors could be used in future studies on risk-adapted follow-up and treatment strategies.
Read More
Malignant Germ Cell Tumors Linked to Higher Stage at Presentation, Adverse Pathologic Features in Older Men
David Ambinder, MD
Testicular, Penile, and Rare Malignancies
|
September 1, 2023
Unique characteristics include higher stage at presentation and a more aggressive subsequent clinical course.
Read More
Is Retroperitoneal Lymph Node Dissection the New Standard of Care for Stage II Seminoma?
David Ambinder, MD
Testicular, Penile, and Rare Malignancies
|
September 1, 2023
It may be time to include RPLND for patients with retroperitoneal disease following treatment for seminoma.
Read More
Atezolizumab With or Without Radiotherapy for Advanced Penile Cancer
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
August 4, 2023
Is atezolizumab plus radiotherapy or atezolizumab monotherapy more effective for advanced penile cancer?
Read More
RPLND for Early Metastatic Seminoma Offers Low Long-term Morbidity
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
June 26, 2023
As chemotherapy and radiotherapy can negatively impact the QOL of cancer survivors, RPLND offers less burden to patients.
Read More
Identifying Risk Factors of Cardiovascular Disease in Testicular Cancer Survivors
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
April 28, 2023
TC treatment, especially platinum-based chemotherapy, is associated with an increased risk of cardiovascular morbidity.
Read More
KRAS Gene Can Indicate Testicular Germ Cell Tumors
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
April 7, 2023
The frequency and role of genomic alterations in testicular germ cell tumors is largely unexplored.
Read More
Retroperitoneal Lymph Node Dissection for Testicular Seminoma: A Phase 2 Trial
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
March 30, 2023
A phase 2 trial examined the safety and efficacy of RPLND as a first-line treatment for early metastatic testicular seminoma.
Read More
Is Surgery the Right Approach for Primary RPLND for Stage II Seminoma?
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
February 27, 2023
Researchers determined the surgical efficacy of RPLND and evaluated recurrence after primary RPLND for CS IIA/IIB seminoma.
Read More
Posttreatment Recurrence and Survival for Locally Advanced Penile Cancer
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
January 12, 2023
A study analyzed 228 patients with penile cancer who underwent pelvic lymph node treatment with curative intent.
Read More
PROs Help Guide Comprehensive Care Plans for Survivors of Testicular Cancer
Zachary Bessette
Testicular, Penile, and Rare Malignancies
|
December 27, 2022
Results from a single-institution trial support using surveys to inform comprehensive plans for testicular cancer survivors.
Read More
Dynamic Sentinel Lymph Node Biopsies for Penile Cancer
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
December 8, 2022
Researchers reviewed the efficacy of sentinel lymph node biopsy as well as further radical inguinal lymph node dissection.
Read More
De-Escalated Combo Treatment for Seminoma Warrants Further Research
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
October 31, 2022
Progression-free survival for stage IIA and stage IIB seminoma was improved with single-dose carboplatin and radiotherapy.
Read More
Certain Ethnic Groups Had Higher Rates of HPV-Associated Penile, Anorectal Cancer
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
October 4, 2022
Hispanic males had the highest incidence of HPV-associated penile cancers and were diagnosed at later stages.
Read More
Neoadjuvant Platinum-Based Chemotherapy Effective for Metastatic Penile SCC
Leah Lawrence
ESMO 2022
|
September 16, 2022
Neoadjuvant platinum-based chemotherapy has been found effective for treating metastatic penile squamous cell carcinoma.
Read More
Neurodevelopmental Disorders Associated With Risk for Testicular Seminoma
Leah Lawrence
ESMO 2022
|
September 16, 2022
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
Read More
Testicular Cancer Survivors at Increased Risk for Skin Cancer
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
August 2, 2022
Many TGCT survivors are referred for life-long monitoring due to an increased risk for skin cancer and melanoma.
Read More
Cancer in the Faroe Islands from 1960-2019—Incidence, Mortality, and Comparisons With the Other Nordic Countries
GU Oncology Now Editors
Urothelial Carcinoma
|
June 3, 2022
In this paper, we present age-standardized cancer incidence and mortality rates in the Faroe Islands.
Read More
Clinical Effect of Retroperitoneal Laparoscopic Radical Nephrectomy on Renal Cell Carcinoma, the Influence of Renal Function, and the Influencing Factors of Recurrence
GU Oncology Now Editors
Renal Cell Carcinoma
|
June 3, 2022
RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.
Read More
Load More
Advertisement
Advertisement
Advertisement